Chesapeake — Investor Presentation (February 2002)
33 slides from Chesapeake's investor presentation, Feb 14, 2002
Slide 1: Investing in Chesapeake, February 11, 2002
favesting en Che SADA Fepruury 11, 2002
Slide 2: Forward-looking statements
This presentation includes forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Changes in the following important factors, among others, could cause Chesapeake’s actual results to differ materially from those expres
Slide 3: What is Chesapeake?
What is Chesapeake? We are one of Europe's largest specialty packaging companies We are focused on the pharma and healthcare; international branded and multimedia & technology sectors We have superior manufacturing and service capabilities throughout Europe And a veteran management team
Slide 4: Transformation of Chesapeake
Briefly, a little information on the transformation of Chesapeake In 1997 we were --- Small player in a tough, capital intensive, kraft paper business --- A mid-sized player in C&I Tissue --- And, a much smaller player in corrugated containers and displays In short , we were capital intensive, cycli
Slide 5: Our primary target markets are...
Our primary target markets are... Why? Because these sectors offer faster growth (5%+ per year vs. 1-3% for commodity markets) and/or greater opportunity for differentiation and, therefore, margin enhancemen t. Our customers require sophisticated design and added value services Our target markets ha
Slide 6: Value-added Defensive Markets
Valu-added Defensive Markets Specialty Land Other Chemical 2% 4% 5% Pharma-Healthcare Food & Household Cosmetics 5% Technology 3% Confectionery Spirits 10% 9% Belgium Other 6% Ireland 5% 6% Germany 9% United States 6% France 9% 2001 Revenues $790 M United Kingdom 59%
Slide 7: Now a little about our business segments
Now a little about our 3 business segments starting with--.
Slide 8: Paperboard packaging: 2001 revenues of $670 million
With 2001 revenues of $670 million, we are a European market leader and Europe's leading pharma and healthcare packaging supplier Our paperboard packaging segment primarily produces folding cartons, labels and leaflets
Slide 9: Significant manufacturing system throughout Europe
We have a significant manufacturing system throughout Europe 43 plants in 7 countries This enables us to offer our customers better service in terms of delivery time and order size
Slide 10: Largest in terms of revenues
Largest in terms of revenues Not tons-that is the essence of the strategy higher $ higher margin target segments Now lets look at our competitors...
Slide 11: Key competitors in pharmaceuticals and tobacco
In pharmaceuticals, our key competitors are Alliances --groups of individual companies that have joined together---However, there is a reluctance to share information (both technical and managerial) with fellow partners -- so, in many ways they remain competitors. Also the status of these Alliances
Slide 12: Now let's talk about our target markets
Now let's talk about our target markets
Slide 13: Text integrity and process controls for customers
Text integrity and rigorous process controls are of paramount concern for our customers Our operations conform to ISO 9001/2 standards and the "Pharmaceutical Supplier Code of Practice" In a recent independent survey of pharma/healthcare companies, 91% of the companies surveyed would prefer to purch
Slide 14: Pharmaceuticals — Text Integrity
Pharmaceuticals — Text Integrity
Slide 15: Premium branded goods: fine spirits and confectionery
Our second target market is premium branded goods--which encompasses fine spirits and confectionery People around the world have more disposable income than ever before-and more consumers are able to buy these products In " image-oriented" markets, a large part of a products brand image is communica
Slide 16: Product Positioning - Fine Spirits
Product Positioning - Fine Spirits == 9%
Slide 17: Range Extension - Confectionery
Range Extension - Confectionery
Slide 18: Tobacco packaging
Another significant market for us is tobacco packaging-- We are one of Europe's largest suppliers of tobacco packaging, a position continuously enhanced through investment in the most advanced international manufacturing infrastructure Our in line gravure printing capabilities are among the best in
Slide 19: Service Extension/Product Positioning
Service Extension/Product Positioning cus eee | iit ‘T CUT cy sILK CU T
Slide 20: Multimedia and technology markets growing faster
Likewise the multimedia and technology markets are expected to grow at even faster rates These customers want innovative packaging and displays as brand awareness and retail presence become more important to their success. And they require just as much, if not more, specialization of packaging to he
Slide 21: Penetrating the technology market, current customer list
While we are just getting started in penetrating this market-..our current list already includes a few industry leaders This business is primarily run out of our Lexington, North Carolina location
Slide 22: Our next business segment
Our next business segment is -
Slide 23: Plastic packaging segment
Our plastic packaging segment serves the specialty chemical, beverages and pharmaceutical sectors We are a niche market leader in: - barrier containers for invasive fluids - PET soft drink containers in South Africa - and HDPE milk bottles in Ireland The division operates from 7 facilities located i
Slide 24: Dominant positions in niche markets
As we said earlier, we have dominant positions in niche markets. This means that, with the exception of the UK soft drinks sector, we have few major direct global competitors
Slide 25: Third business segment: remaining legacy assets
Our third business segment and only remaining legacy assets are...
Slide 26: Valuable Land Assets
ValuableLandAssets ## #=$= «© come Chesapeake’s land portfolio consists of approximately 20,000 acres Well-situated in Eastern Virginia — Washington, D.C. to Richmond to Williamsburg to Norfolk, VA Sold to developers and individual buyers for commercial and residential use Strategy — Maximize the va
Slide 27: Financial Overview
Slide 28: Pro Forma Historical Financial Data
Pro Forma Historical Financial Data ~~ 2 Continuing Operations (Dollars in Millions) FY ENDED 1998 1999 2000 2001 Sales $ 770 $ 809 $ 801 $ 790 % Growth Constant Currency - 7.6% 9.0% 3.3% EBITDA* $ 105 $ 123 $ 131 $ 121 % Margin 13.7% 15.2% 16.4% 15.3% EBIT* $ 44 $ 55 $ 68 $ 61 % Margin 5.8% 6.8% 8.
Slide 29: Pro Forma Historical Segment Results
Continuing Operations (Dollars in Millions) Pro Forma Historical Segment Results 2000 2001 Sales Paperboard Packaging $ 678 $ 671 Plastic Packaging 102 98 Land Development Pl 21 Total $ 801 $ 790 EBITDA* Paperboard Packaging $ 113 $ 111 Plastic Packaging 18 13 Land Development 16 15 Corporate (16) (
Slide 30: Capital Structure
Capital Structure (8 millions) Net Debt Deferred Taxes Shareholders’ Equity Total Capital Net Debt/Capital 12/31/00 651 12/31/01 470 50 %
Slide 31: Financial Outlook 2002
Financial Outlook 2002 Continuing Operations Revenues $780 — 820 million Depreciation $45 - 50 million Capex $55 — 65 million EBITDA $125-135 million Net Income $1.60 - 1.80/share
Slide 32: Top priority is operational excellence
This year our top priority is operational excellence, strengthening our balance sheet, and reducing overhead Next year and beyond, our priorities include a North American folding carton platform and increased penetration in technology and multimedia However, we intend to apply discipline to our valu
Slide 33: Investing in Chesapeake, February 11, 2002
favesting en Che SADA Fepruury 11, 2002